194 related articles for article (PubMed ID: 32655937)
1. Surgical management of primary pancreatic neuroendocrine tumors.
Johnston ME; Carter MM; Wilson GC; Ahmad SA; Patel SH
J Gastrointest Oncol; 2020 Jun; 11(3):578-589. PubMed ID: 32655937
[TBL] [Abstract][Full Text] [Related]
2. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
[TBL] [Abstract][Full Text] [Related]
3. Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review.
Williams JK; Schwarz JL; Keutgen XM
Hepatobiliary Surg Nutr; 2023 Feb; 12(1):69-83. PubMed ID: 36860243
[TBL] [Abstract][Full Text] [Related]
4. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas.
Gharios J; Hain E; Dohan A; Prat F; Terris B; Bertherat J; Coriat R; Dousset B; Gaujoux S
Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101294. PubMed ID: 31351817
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study.
Paiella S; De Pastena M; Landoni L; Esposito A; Casetti L; Miotto M; Ramera M; Salvia R; Secchettin E; Bonamini D; Manzini G; D'Onofrio M; Marchegiani G; Bassi C
Surg Endosc; 2017 Nov; 31(11):4478-4484. PubMed ID: 28374260
[TBL] [Abstract][Full Text] [Related]
6. Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.
Singhi AD; Klimstra DS
Histopathology; 2018 Jan; 72(1):168-177. PubMed ID: 29239037
[TBL] [Abstract][Full Text] [Related]
7. Treatment Options for Pancreatic Neuroendocrine Tumors.
Akirov A; Larouche V; Alshehri S; Asa SL; Ezzat S
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31207914
[TBL] [Abstract][Full Text] [Related]
8. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors.
Kulali F; Semiz-Oysu A; Demir M; Segmen-Yilmaz M; Bukte Y
Diagn Interv Imaging; 2018 May; 99(5):301-309. PubMed ID: 29258825
[TBL] [Abstract][Full Text] [Related]
9. Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors.
Carter AM; Kumar N; Herring B; Tan C; Guenter R; Telange R; Howse W; Viol F; McCaw TR; Bickerton HH; Gupta P; Gillardon F; Woltering EA; Dhall D; Totenhagen J; Banerjee RR; Kurian EM; Reddy S; Chen H; Schrader J; Bart Rose J; Mukhtar MS; Bibb JA
Oncogenesis; 2021 Dec; 10(12):83. PubMed ID: 34862365
[TBL] [Abstract][Full Text] [Related]
10. Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review.
Maiorano BA; Schinzari G; Chiloiro S; Visconti F; Milardi D; Bianchi A
Protein Pept Lett; 2020; 27(12):1276-1287. PubMed ID: 31804164
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication.
Taskin OC; Clarke CN; Erkan M; Tsai S; Evans DB; Adsay V
J Gastrointest Oncol; 2020 Jun; 11(3):548-558. PubMed ID: 32655934
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any?
Gallo M; Ruggeri RM; Muscogiuri G; Pizza G; Faggiano A; Colao A;
Cancer Treat Rev; 2018 Jun; 67():1-9. PubMed ID: 29746922
[TBL] [Abstract][Full Text] [Related]
13. Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series.
Paiella S; Marchegiani G; Miotto M; Malpaga A; Impellizzeri H; Montagnini G; Pollini T; Nessi C; Butturini G; Capelli P; Posenato I; Scarpa A; D'Onofrio M; De Robertis R; Cingarlini S; Boninsegna L; Bassi C; Salvia R; Landoni L
Neuroendocrinology; 2018; 106(3):234-241. PubMed ID: 28586782
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study Protocol.
Pea A; Tanno L; Nykänen T; Prasad P; Tunçer C; Robinson S; Marchegiani G
Front Med (Lausanne); 2020; 7():559. PubMed ID: 33015105
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study.
Zhang P; Li YL; Qiu XD; Luo J; Shi YF; Sun YL; Su F; Qi ZR; Tan HY
World J Surg Oncol; 2019 Apr; 17(1):66. PubMed ID: 30975157
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
17. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study.
Singhi AD; Chu LC; Tatsas AD; Shi C; Ellison TA; Fishman EK; Kawamoto S; Schulick RD; Wolfgang CL; Hruban RH; Edil BH
Am J Surg Pathol; 2012 Nov; 36(11):1666-73. PubMed ID: 23073325
[TBL] [Abstract][Full Text] [Related]
18. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
[TBL] [Abstract][Full Text] [Related]
19. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance.
Lee NJ; Hruban RH; Fishman EK
Abdom Radiol (NY); 2018 Nov; 43(11):3025-3034. PubMed ID: 29594467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
